UBS Group’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.5K | Buy |
2,274
+965
| +74% | +$2.89K | ﹤0.01% | 8683 |
|
|
2025
Q4 | $4.23K | Sell |
1,309
-224
| -15% | -$724 | ﹤0.01% | 8867 |
|
|
2025
Q3 | $3.69K | Sell |
1,533
-5,282
| -78% | -$15.1K | ﹤0.01% | 9024 |
|
|
2025
Q2 | $33.1K | Sell |
6,815
-1,054
| -13% | -$3.17K | ﹤0.01% | 8095 |
|
|
2025
Q1 | $11.6K | Hold |
7,869
| – | – | ﹤0.01% | 8543 |
|
|
2024
Q4 | $15K | Buy |
7,869
+6,841
| +665% | +$15.2K | ﹤0.01% | 8060 |
|
|
2024
Q3 | $3.31K | Sell |
1,028
-4,457
| -81% | -$16K | ﹤0.01% | 8287 |
|
|
2024
Q2 | $38.3K | Buy |
5,485
+3,866
| +239% | +$46.1K | ﹤0.01% | 6891 |
|
|
2024
Q1 | $29.3K | Buy |
1,619
+591
| +57% | +$11.8K | ﹤0.01% | 6751 |
|
|
2023
Q4 | $10.9K | Sell |
1,028
-717
| -41% | -$8.63K | ﹤0.01% | 7412 |
|
|
2023
Q3 | $34.5K | Buy |
1,745
+80
| +5% | +$3.45K | ﹤0.01% | 6520 |
|
|
2023
Q2 | $127K | Sell |
1,665
-7
| -0.4% | -$566 | ﹤0.01% | 5822 |
|
|
2023
Q1 | $158K | Sell |
1,672
-140
| -8% | -$13.3K | ﹤0.01% | 5576 |
|
|
2022
Q4 | $177K | Sell |
1,812
-112
| -6% | -$16.2K | ﹤0.01% | 5560 |
|
|
2022
Q3 | $496K | Buy |
1,924
+136
| +8% | +$39.5K | ﹤0.01% | 4351 |
|
|
2022
Q2 | $333K | Sell |
1,788
-444
| -20% | -$42.4K | ﹤0.01% | 4568 |
|
|
2022
Q1 | $218K | Sell |
2,232
-4,531
| -67% | -$582K | ﹤0.01% | 5285 |
|
|
2021
Q4 | $1.11M | Buy |
6,763
+1,880
| +39% | +$413K | ﹤0.01% | 4297 |
|
|
2021
Q3 | $1.33M | Buy |
4,883
+2,516
| +106% | +$769K | ﹤0.01% | 3932 |
|
|
2021
Q2 | $938K | Sell |
2,367
-2,411
| -50% | -$1.13M | ﹤0.01% | 4231 |
|
|
2021
Q1 | $2.58M | Buy |
4,778
+2,074
| +77% | +$1.29M | ﹤0.01% | 3304 |
|
|
2020
Q4 | $1.02M | Sell |
2,704
-267
| -9% | -$106K | ﹤0.01% | 4003 |
|
|
2020
Q3 | $1.12M | Sell |
2,971
-723
| -20% | -$319K | ﹤0.01% | 3553 |
|
|
2020
Q2 | $1.82M | Sell |
3,694
-618
| -14% | -$276K | ﹤0.01% | 2970 |
|
|
2020
Q1 | $1.58M | Sell |
4,312
-288
| -6% | -$149K | ﹤0.01% | 2975 |
|
|
2019
Q4 | $3.26M | Sell |
4,600
-1,704
| -27% | -$1.17M | ﹤0.01% | 3043 |
|
|
2019
Q3 | $4.05M | Buy |
6,304
+2,615
| +71% | +$2.07M | ﹤0.01% | 2581 |
|
|
2019
Q2 | $3.23M | Buy |
3,689
+606
| +20% | +$417K | ﹤0.01% | 2708 |
|
|
2019
Q1 | $1.78M | Sell |
3,083
-1,972
| -39% | -$824K | ﹤0.01% | 3083 |
|
|
2018
Q4 | $1.42M | Buy |
5,055
+1,662
| +49% | +$657K | ﹤0.01% | 3371 |
|
|
2018
Q3 | $1.63M | Sell |
3,393
-208
| -6% | -$89.2K | ﹤0.01% | 3398 |
|
|
2018
Q2 | $1.63M | Sell |
3,601
-2,215
| -38% | -$1.4M | ﹤0.01% | 3347 |
|
|
2018
Q1 | $3.42M | Buy |
5,816
+1,519
| +35% | +$947K | ﹤0.01% | 2659 |
|
|
2017
Q4 | $2.67M | Sell |
4,297
-274
| -6% | -$197K | ﹤0.01% | 2940 |
|
|
2017
Q3 | $4.21M | Buy |
4,571
+168
| +4% | +$149K | ﹤0.01% | 2377 |
|
|
2017
Q2 | $4.11M | Buy |
4,403
+201
| +5% | +$197K | ﹤0.01% | 2333 |
|
|
2017
Q1 | $4M | Sell |
4,202
-1,230
| -23% | -$1.15M | ﹤0.01% | 2287 |
|
|
2016
Q4 | $4.36M | Buy |
5,432
+1,340
| +33% | +$1.21M | ﹤0.01% | 2215 |
|
|
2016
Q3 | $3.46M | Sell |
4,092
-592
| -13% | -$476K | ﹤0.01% | 2374 |
|
|
2016
Q2 | $3.86M | Buy |
4,684
+820
| +21% | +$893K | ﹤0.01% | 2183 |
|
|
2016
Q1 | $4.3M | Sell |
3,864
-2,168
| -36% | -$2.22M | ﹤0.01% | 1997 |
|
|
2015
Q4 | $7.52M | Buy |
6,032
+2,446
| +68% | +$4.05M | 0.01% | 1633 |
|
|
2015
Q3 | $4.85M | Buy |
3,586
+973
| +37% | +$1.61M | ﹤0.01% | 1947 |
|
|
2015
Q2 | $4.7M | Buy |
2,613
+103
| +4% | +$160K | ﹤0.01% | 2139 |
|
|
2015
Q1 | $4.05M | Buy |
2,510
+463
| +23% | +$686K | ﹤0.01% | 2246 |
|
|
2014
Q4 | $1.56M | Buy |
+2,047
| New | +$1.09M | ﹤0.01% | 3147 |
|
Other funds holding TCRT
VFT
VCM
HF
XT
TRCT